Title : Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.

Pub. Date : 2022 Jan

PMID : 32838660






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tegobuvir, a non-nucleoside inhibitor of the hepatitis C virus, also exhibited maximum stability along with the highest binding energy (-8.1 Kcal/mol) at the active site of the spike proteins. tegobuvir surface glycoprotein Severe acute respiratory syndrome coronavirus 2